NCT01863615View on ClinicalTrials.gov

Bioequivalence Study for an Isotretinoin

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 26, 2011

Primary Completion Date

September 23, 2011

Study Completion Date

September 23, 2011

Conditions
Skin Infections (Acne)
Interventions
DRUG

Isotretinoin 40 mg

Roaccutan 2 capsules of 20 mg; reference drug

DRUG

Isotretinoin 40 mg

Oratane 2 capsules of 20 mg; test drug

Trial Locations (1)

64600

GSK Investigational Site, Monterrey

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01863615 - Bioequivalence Study for an Isotretinoin | Biotech Hunter | Biotech Hunter